In Asia, Approximately 70% of patients have genetic polymorphism, DNA repair, overexpression of p53, presence of BRCA1 and BRCA2, and other hereditary characteristics (Figure 2), whereas the risk of BC in other regions due to genetic mutation is comparatively low. This evidence concerns the gene BRCA1 and breast cancer.